International Stem Cell Corporation (ISCO)
ISCO Stock Price Chart
Explore International Stem Cell Corporation interactive price chart. Choose custom timeframes to analyze ISCO price movements and trends.
ISCO Company Profile
Discover essential business fundamentals and corporate details for International Stem Cell Corporation (ISCO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 May 2007
Employees
32.00
CEO
Andrey Semechkin
Description
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.
ISCO Financial Timeline
Browse a chronological timeline of International Stem Cell Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at $0.01 , while revenue for the quarter reached $2.45M .
Earnings released on 14 May 2025
EPS came in at -$0.03 , while revenue for the quarter reached $2.13M .
Earnings released on 28 Mar 2025
EPS came in at $0.00 , while revenue for the quarter reached $2.45M .
Earnings released on 13 Nov 2024
EPS came in at -$0.02 , while revenue for the quarter reached $2.18M .
Earnings released on 13 Aug 2024
EPS came in at $0.01 , while revenue for the quarter reached $2.33M .
Earnings released on 14 May 2024
EPS came in at -$0.03 , while revenue for the quarter reached $2.13M .
Earnings released on 28 Mar 2024
EPS came in at -$0.04 , while revenue for the quarter reached $1.89M .
Earnings released on 13 Nov 2023
EPS came in at -$0.02 , while revenue for the quarter reached $1.97M .
Earnings released on 11 Aug 2023
EPS came in at $0.03 , while revenue for the quarter reached $1.84M .
Earnings released on 12 May 2023
EPS came in at -$0.01 , while revenue for the quarter reached $2.09M .
Earnings released on 30 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $2.43M .
Earnings released on 14 Nov 2022
EPS came in at -$0.04 , while revenue for the quarter reached $1.70M .
Earnings released on 12 Aug 2022
EPS came in at -$0.00 , while revenue for the quarter reached $2.03M .
Earnings released on 17 May 2022
EPS came in at -$0.01 , while revenue for the quarter reached $2.02M .
Earnings released on 30 Mar 2022
EPS came in at -$0.04 , while revenue for the quarter reached $1.84M .
Earnings released on 12 Nov 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.84M .
Earnings released on 13 Aug 2021
EPS came in at -$0.06 , while revenue for the quarter reached $1.83M .
Earnings released on 14 May 2021
EPS came in at -$0.08 , while revenue for the quarter reached $1.66M .
Earnings released on 30 Mar 2021
EPS came in at -$0.09 , while revenue for the quarter reached $1.48M .
Earnings released on 12 Nov 2020
EPS came in at -$0.07 , while revenue for the quarter reached $1.48M .
ISCO Stock Performance
Access detailed ISCO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.